Dr Lu Li
| PhD, Pathobiology | Location: Sydney, AU
Dr Lu Li is an investment analyst in OneVentures’ Healthcare team.
Lu supports the Healthcare team by performing quantitative and qualitative research to inform investment, valuation and exit decisions. Lu also assists with deal screening and performing due diligence whilst also reporting and monitoring existing and prospective fund investments.
Lu regularly practices meditation and loves to study herbal medicine. She also paints and sketches in her free time.
Lu brings over 7 years of biomedical research experience in academia to the OneVentures team. She has a strong technical background on research & development in general, and always follows the latest research progress.
In addition, Lu brings her depth of experience for financial modelling and equity research, along with her keen interest in finance.
Prior to joining with OneVentures, Lu joined CITIC’s Biotech Equity Research area as an intern. She later worked as a scientific writer and technical consultant at DeepTech, a new media platform, where she covers biotech startups and latest biomedical research, and simultaneously completed level 2 of the CFA.
Lu received her Ph.D in Pathobiology from the University of Connecticut in the US, where she focused her research on infectious disease pathogenesis.